Literature DB >> 18843248

Continuous monitoring and intervention for cerebral ischemia in tuberculous meningitis.

Anthony A Figaji1, Simon I J Sandler, A Graham Fieggen, Peter D Le Roux, Jonathan C Peter, Andrew C Argent.   

Abstract

OBJECTIVE: Tuberculous meningitis (TBM) is a massive global problem. The mortality and morbidity associated with the severe form of the disease are exceptionally high. Even when increased intracranial pressure is treated and full conventional therapy is commenced, cerebral ischemia can develop and is associated with a particularly poor prognosis. We sought to evaluate our experience with two patients with severe TBM and cerebral oxygenation monitoring.
DESIGN: Case report.
SETTING: Red Cross Children's Hospital, Cape Town. PATIENTS: Two comatose patients with TBM.
INTERVENTIONS: Targeted interventions against low cerebral oxygenation in one patient.
MEASUREMENTS AND MAIN RESULTS: Cerebral tissue oxygenation (Ptio2) was measured. In both patients, Ptio2 monitoring demonstrated delayed cerebral ischemia despite the institution of full conventional therapy and the control of intracranial pressure. These data confirm that the vascular involvement in TBM is potentially progressive and that failure to diagnose infarction initially is not merely due to a delay in the radiologic appearance. The first patient developed extensive infarction, consistent with Ptio2 readings, and subsequently died after treatment withdrawal. Intervention in the second patient successfully reversed a precipitous decline of the Ptio2 readings and may have prevented infarction in this patient.
CONCLUSIONS: The development of delayed cerebral ischemia in TBM despite treatment is confirmed in these two patients. The reversal of a decline in Ptio2 readings suggests a possible benefit for cerebral oxygenation monitoring in selected patients with severe TBM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843248     DOI: 10.1097/PCC.0b013e318172e8b7

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  7 in total

Review 1.  Tuberculosis of the central nervous system in children.

Authors:  Dattatraya Muzumdar; Rajshekhar Vedantam; Deopujari Chandrashekhar
Journal:  Childs Nerv Syst       Date:  2018-07-05       Impact factor: 1.475

Review 2.  Multimodal Neurologic Monitoring in Children With Acute Brain Injury.

Authors:  Jennifer C Laws; Lori C Jordan; Lindsay M Pagano; John C Wellons; Michael S Wolf
Journal:  Pediatr Neurol       Date:  2022-02-02       Impact factor: 3.372

Review 3.  A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa.

Authors:  Yohannes W Woldeamanuel; Belaineh Girma
Journal:  J Neurol       Date:  2013-08-21       Impact factor: 4.849

Review 4.  Standardized Methods for Enhanced Quality and Comparability of Tuberculous Meningitis Studies.

Authors:  Ben J Marais; Anna D Heemskerk; Suzaan S Marais; Reinout van Crevel; Ursula Rohlwink; Maxine Caws; Graeme Meintjes; Usha K Misra; Nguyen T H Mai; Rovina Ruslami; James A Seddon; Regan Solomons; Ronald van Toorn; Anthony Figaji; Helen McIlleron; Robert Aarnoutse; Johan F Schoeman; Robert J Wilkinson; Guy E Thwaites
Journal:  Clin Infect Dis       Date:  2017-02-15       Impact factor: 9.079

5.  Checklists to guide the supportive and critical care of tuberculous meningitis.

Authors:  Joseph Donovan; Ursula K Rohlwink; Elizabeth W Tucker; Nguyen Thi Thu Hiep; Guy E Thwaites; Anthony A Figaji
Journal:  Wellcome Open Res       Date:  2019-10-31

6.  A pilot study of inflammatory mediators in brain extracellular fluid in paediatric TBM.

Authors:  Nicholas W Loxton; Ursula K Rohlwink; Mvuwo Tshavhungwe; Lindizwe Dlamini; Muki Shey; Nico Enslin; Anthony Figaji
Journal:  PLoS One       Date:  2021-03-12       Impact factor: 3.240

7.  Knowledge gaps and research priorities in tuberculous meningitis.

Authors:  James A Seddon; Robert Wilkinson; Reinout van Crevel; Anthony Figaji; Guy E Thwaites
Journal:  Wellcome Open Res       Date:  2019-11-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.